GO:0140345 phosphatidylcholine flippase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140345 phosphatidylcholine flippase activity describes the ATP-dependent movement of phosphatidylcholine from the exoplasmic to the cytosolic leaflet of a membrane.
• This activity is catalyzed by P4-ATPases, a subfamily of P-type ATPases that includes ATP8B1, ATP8B2, ATP10A, ATP11A, ATP11B, and ATP11C [1, 3, 6, 7].
• Phosphatidylcholine flippase activity is essential for maintaining membrane lipid asymmetry, which influences vesicle trafficking, cell signaling, and membrane dynamics.
• Mutations in phosphatidylcholine flippases are linked to liver disease, neurological disorders, and cancer [1, 4].
• Cryo-EM and biochemical assays have revealed conformational changes and substrate specificity of phosphatidylcholine flippases [3, 7].
• CRISPR-based models (knockout, point mutation, knock-in) are powerful tools to dissect the physiological roles of phosphatidylcholine flippases [1, 6].
Description
Phosphatidylcholine flippase activity (GO:0140345) is a molecular function that catalyzes the ATP-dependent translocation of phosphatidylcholine from the exoplasmic (outer) leaflet to the cytosolic (inner) leaflet of cellular membranes. This activity is critical for establishing and maintaining the asymmetric distribution of phospholipids across the lipid bilayer, a hallmark of eukaryotic plasma membranes and intracellular organelles. The enzymes responsible for this activity belong to the P4-ATPase family, which includes ATP8B1, ATP8B2, ATP10A, ATP11A, ATP11B, and ATP11C [1, 3, 6, 7]. Researchers study phosphatidylcholine flippase activity to understand fundamental membrane biology, including how cells regulate lipid asymmetry, membrane curvature, and vesicle formation. Dysregulation of this activity has been implicated in a range of human diseases, from cholestatic liver disease to neurological disorders and cancer [1, 4]. Recent structural and biochemical studies have provided mechanistic insights into how these flippases recognize and transport phosphatidylcholine [3, 7]. This article provides a comprehensive overview of GO:0140345, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental approaches for studying it. By integrating authoritative QuickGO data with verified PubMed literature, we aim to support researchers in designing robust experiments and interpreting their findings in the context of membrane lipid dynamics.
phosphatidylcholine flippase activity At A Glance
| GO ID | GO:0140345 |
|---|---|
| GO term | phosphatidylcholine flippase activity |
| Ontology | molecular_function |
| Synonym | phosphatidylcholine flippase activity (exoplasmic to cytosolic leaflet) |
| Major function | ATP-dependent translocation of phosphatidylcholine from the exoplasmic to the cytosolic leaflet of a membrane |
| Catalytic mechanism | ATP hydrolysis drives conformational changes that flip phosphatidylcholine across the lipid bilayer |
| Representative enzymes | P4-ATPases such as ATP8B1, ATP8B2, ATP10A, ATP11A, ATP11B, ATP11C |
| Subcellular location | Plasma membrane, endosomes, Golgi, and other secretory organelles |
| Associated diseases | Cholestasis, neurological disorders, cancer |
What Is GO:0140345?
Phosphatidylcholine flippase activity (GO:0140345) is defined as the catalysis of the movement of phosphatidylcholine from the exoplasmic to the cytosolic leaflet of a membrane, using energy from the hydrolysis of ATP. This activity is a type of phospholipid-translocating ATPase activity and is synonymous with phosphatidylcholine flippase activity (exoplasmic to cytosolic leaflet). It is a molecular function that contributes to the maintenance of membrane lipid asymmetry and is carried out by P4-ATPases [1, 6].
Why Is phosphatidylcholine flippase activity Important in Cell Biology?
Phosphatidylcholine flippase activity is fundamental to membrane biology because it establishes and maintains the asymmetric distribution of phosphatidylcholine across the lipid bilayer, a feature essential for membrane integrity, vesicle trafficking, and cell signaling. Disruption of this activity leads to loss of lipid asymmetry, which can trigger pathological processes such as cholestasis, neurodegeneration, and tumor progression [1, 4]. Understanding the molecular mechanism of phosphatidylcholine flippases is therefore critical for developing therapeutic strategies targeting these enzymes.
• Maintains membrane lipid asymmetry, which is crucial for cell polarity and signaling.
• Regulates vesicle budding and fusion by controlling lipid packing and membrane curvature.
• Mutations in ATP8B2 impair phosphatidylcholine flippase activity and are associated with neurological disorders.
• ATP8B1 deficiency causes progressive familial intrahepatic cholestasis, highlighting its role in liver disease.
• ATP10A translocates phosphatidylcholine and influences plasma membrane dynamics, with implications for metabolic disorders.
• ATP11C mutations affect phospholipid recognition and can lead to blood disorders and cancer.
• Phosphatidylcholine flippases are potential drug targets for cancer and liver diseases.
• Studying flippase activity informs synthetic biology approaches to engineer membrane properties.
What Happens During phosphatidylcholine flippase activity?
Substrate Recognition and Binding
In simple terms: The flippase enzyme first grabs a phosphatidylcholine molecule from the outer side of the membrane.
Phosphatidylcholine flippases, such as ATP8B2 and ATP10A, specifically recognize phosphatidylcholine headgroups within the exoplasmic leaflet of the lipid bilayer [1, 6]. Structural studies of the ATP11C Q79E mutant reveal that a conserved glutamine residue is critical for phospholipid recognition, and its mutation alters substrate specificity. The binding site accommodates the phosphatidylcholine molecule in a hydrophobic pocket, positioning it for translocation.
ATP Hydrolysis and Conformational Change
In simple terms: The enzyme uses energy from ATP to change its shape, which pushes the lipid across the membrane.
Upon substrate binding, the flippase hydrolyzes ATP, leading to autophosphorylation of a conserved aspartate residue and a large conformational change between the E1 and E2 states. This cycle is characteristic of P-type ATPases and drives the movement of phosphatidylcholine across the membrane. Cryo-EM structures of phosphatidylcholine flippases in lipid membranes have captured distinct conformational states that reveal how the lipid is flipped.
Translocation and Release
In simple terms: The lipid is released on the inner side of the membrane, completing the flip.
Following the conformational change, phosphatidylcholine is released into the cytosolic leaflet, and the enzyme returns to its resting state. This process maintains the asymmetric distribution of phosphatidylcholine, which is essential for membrane function. The flippase activity of gastric vesicles demonstrates that this mechanism is conserved across different cell types.
Membrane Dynamics and Vesicle Trafficking
In simple terms: By moving lipids, the flippase helps shape the membrane and control how vesicles form and move.
Phosphatidylcholine flippase activity contributes to membrane curvature and vesicle budding by altering lipid packing in the cytosolic leaflet. ATP10A, for example, is involved in plasma membrane dynamics, and its flippase activity influences endocytosis and exocytosis. This activity also affects the recruitment of peripheral membrane proteins that sense lipid asymmetry.
Key Genes Involved in GO:0140345 phosphatidylcholine flippase activity
The following genes encode proteins that exhibit phosphatidylcholine flippase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP8B1 | P4-ATPase that flips phosphatidylcholine; mutations cause cholestasis | Liver disease models; knockout mice develop cholestasis |
| ATP8B2 | Phosphatidylcholine flippase; de novo missense variants impair activity | Neurological disorder models; point mutation studies |
| ATP10A | Translocates phosphatidylcholine; regulates plasma membrane dynamics | Metabolic and neurological studies; knockout and overexpression models |
| ATP11A | P4-ATPase with phosphatidylcholine flippase activity | Cancer and membrane asymmetry research |
| ATP11B | Phosphatidylcholine flippase involved in membrane trafficking | Cell biology and vesicle transport studies |
| ATP11C | Phosphatidylcholine flippase; Q79E mutant alters lipid recognition | Blood disorders and cancer; structural studies |
| TMEM16F | Scramblase that affects phospholipid distribution; not a flippase but modulates asymmetry | Assays for phospholipid headgroup preference |
| CDC50A | Chaperone subunit for P4-ATPases; required for flippase maturation | Knockout models to study flippase trafficking |
| CDC50B | Chaperone subunit for P4-ATPases | Interaction studies with ATP8B2 |
| ATP8A1 | P4-ATPase with phosphatidylserine flippase activity; may also flip phosphatidylcholine | Comparative studies of substrate specificity |
| ATP8A2 | P4-ATPase with phosphatidylserine flippase activity | Neurological disorder models |
| ATP9A | P4-ATPase involved in membrane trafficking | Studies of flippase family diversity |
| ATP9B | P4-ATPase with unclear substrate specificity | Functional characterization studies |
| ATP10B | P4-ATPase potentially involved in phosphatidylcholine flipping | Metabolic and neurological research |
| ATP10D | P4-ATPase with phosphatidylcholine flippase activity | Membrane dynamics studies |
| ATP11A | P4-ATPase with phosphatidylcholine flippase activity | Cancer and membrane asymmetry research |
How Is phosphatidylcholine flippase activity Regulated?
Phosphatidylcholine flippase activity is regulated at multiple levels. The catalytic activity of P4-ATPases is dependent on ATP and is influenced by the lipid composition of the membrane. Interaction with CDC50 family chaperones is required for proper folding and exit from the endoplasmic reticulum. Post-translational modifications, such as phosphorylation, may modulate flippase activity, although specific pathways remain to be fully elucidated. Additionally, the activity of phosphatidylinositol flippases can affect phosphoinositide homeostasis, which in turn may influence phosphatidylcholine flippase function indirectly. In the liver, bile acid signaling and membrane lipid composition regulate ATP8B1 activity, and its dysfunction leads to cholestasis.
phosphatidylcholine flippase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP8B1 | Progressive familial intrahepatic cholestasis | Liver-specific knockout mice; patient-derived iPSCs |
| ATP8B2 | Neurological disorders | Knock-in mice with patient mutations; neuronal cultures |
| ATP10A | Metabolic and neurological disorders | Knockout and overexpression in cell lines; primary neurons |
| ATP11C | Blood disorders and cancer | Point mutation knock-in (Q79E); hematopoietic stem cells |
| TMEM16F | Scott syndrome and phospholipid scrambling | Knockout cells; scrambling assays |
Liver Disease and Cholestasis
ATP8B1 deficiency causes progressive familial intrahepatic cholestasis type 1, a severe liver disease characterized by impaired bile flow. The loss of phosphatidylcholine flippase activity in hepatocytes disrupts canalicular membrane lipid asymmetry, leading to bile salt toxicity and liver damage. Studies in model systems have shown that restoration of ATP8B1 function can ameliorate cholestasis, highlighting the therapeutic potential of targeting this flippase.
Neurological Disorders
De novo missense variations in ATP8B2 that impair its phosphatidylcholine flippase activity have been identified in patients with neurological disorders. These mutations affect the enzyme's ability to flip phosphatidylcholine, leading to altered membrane dynamics in neurons. Additionally, ATP10A has been implicated in neurological conditions, and its flippase activity is important for plasma membrane dynamics in neurons.
Cancer and Blood Disorders
Altered expression of phosphatidylcholine flippases, such as ATP11C, has been observed in various cancers and blood disorders. The Q79E mutation in ATP11C alters phospholipid recognition, which may contribute to disease pathogenesis. Loss of lipid asymmetry due to flippase dysfunction can expose phosphatidylserine on the cell surface, promoting blood coagulation and immune recognition, processes relevant to cancer and thrombosis.
From phosphatidylcholine flippase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of phosphatidylcholine flippase activity? | CRISPR knockout of ATP8B2 or ATP10A in cell lines [1, 6] |
| How do disease-associated point mutations affect flippase activity? | CRISPR point mutation knock-in of ATP8B2 variants |
| Can we visualize flippase localization and dynamics? | Knock-in of fluorescent tags (e.g., GFP) into endogenous ATP8B1 locus |
| What happens when flippase is overexpressed? | Overexpression of ATP10A in cultured cells |
| How does flippase activity affect membrane lipid asymmetry? | CRISPR knockout combined with lipid asymmetry assays |
| What are the interaction partners of flippases? | Knock-in of affinity tags (e.g., FLAG) for proteomics |
How to Study the phosphatidylcholine flippase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent lipid flipping assay | ATP-dependent translocation of phosphatidylcholine | Reconstituted vesicles or intact cells |
| Cryo-EM | Three-dimensional structure of flippase in lipid membranes | Conformational changes during transport |
| CRISPR knockout | Loss-of-function effects on membrane asymmetry | Cell lines and animal models |
| CRISPR point mutation knock-in | Effect of disease-associated mutations | ATP8B2 variants in neuronal cells |
| Overexpression | Gain-of-function effects on membrane dynamics | ATP10A in cultured cells |
| Lipidomics (mass spectrometry) | Quantification of phosphatidylcholine species | Membrane leaflet distribution |
| Annexin V staining | Phosphatidylserine exposure as a readout of asymmetry | Scramblase and flippase studies |
| Proteomics (affinity purification) | Interaction partners of flippases | CDC50 chaperone interactions |
Biochemical Assays for Flippase Activity
Flippase activity can be measured using fluorescently labeled phosphatidylcholine analogs in reconstituted vesicles or intact cells. The gastric vesicle assay developed by Suzuki et al. demonstrated ATP-dependent flipping of phosphatidylcholine. More recent cell-based scrambling assays can distinguish flippase from scramblase activity.
Structural Biology Approaches
Cryo-electron microscopy (cryo-EM) has been used to determine the structures of phosphatidylcholine flippases in lipid membranes, revealing conformational changes during the transport cycle. The cryo-EM structure of the ATP11C Q79E mutant provided insights into altered phospholipid recognition. These methods are essential for understanding the molecular mechanism of flippases.
Genetic and CRISPR Screens
CRISPR knockout screens can identify genes that regulate phosphatidylcholine flippase activity or are synthetic lethal with flippase loss. Point mutation knock-in models are valuable for studying disease-associated variants, such as ATP8B2 missense mutations. Overexpression studies help elucidate the effects of increased flippase levels on membrane dynamics.
Lipidomics and Imaging
Mass spectrometry-based lipidomics can quantify phosphatidylcholine distribution across membrane leaflets. Fluorescence microscopy with lipid probes, such as annexin V for phosphatidylserine, can assess membrane asymmetry in live cells. These techniques complement biochemical assays to provide a comprehensive view of flippase function.
How CRISPR Can Be Used to Study GO:0140345 phosphatidylcholine flippase activity
Knockout
CRISPR knockout of phosphatidylcholine flippase genes, such as ATP8B2 or ATP10A, allows researchers to study the consequences of complete loss of activity on membrane lipid asymmetry, vesicle trafficking, and cell viability [1, 6]. Knockout cell lines can be used in synthetic lethality screens to identify compensatory pathways.
Point Mutation
CRISPR point mutation knock-in introduces specific disease-associated mutations, such as the ATP8B2 missense variants identified in neurological disorders, to assess their impact on flippase activity and cellular function. This approach is ideal for modeling human genetic diseases in isogenic cell lines.
Knock-in
Knock-in of fluorescent or affinity tags into endogenous flippase loci enables real-time imaging of protein localization and dynamics, as well as proteomic identification of interaction partners. Tagged knock-in models preserve endogenous expression levels and regulation.
Overexpression
Overexpression of phosphatidylcholine flippases, such as ATP10A, can reveal gain-of-function phenotypes, including altered plasma membrane dynamics and lipid distribution. This approach is useful for studying the effects of elevated flippase activity in disease contexts.
How EDITGENE Supports phosphatidylcholine flippase activity Research
Researchers studying phosphatidylcholine flippase activity-related genes often need to determine whether a candidate gene is causally involved in membrane lipid asymmetry, vesicle trafficking, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutation knock-in and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylcholine flippase activity research.
Frequently Asked Questions About phosphatidylcholine flippase activity
What is phosphatidylcholine flippase activity?
Phosphatidylcholine flippase activity (GO:0140345) is the ATP-dependent movement of phosphatidylcholine from the exoplasmic to the cytosolic leaflet of a membrane, catalyzed by P4-ATPases.
What genes are involved in phosphatidylcholine flippase activity?
Key genes include ATP8B1, ATP8B2, ATP10A, ATP11A, ATP11B, and ATP11C, which encode P4-ATPase flippases [1, 3, 6, 7].
Which diseases are associated with phosphatidylcholine flippase mutations?
Mutations in ATP8B1 cause cholestasis, ATP8B2 variants are linked to neurological disorders, and ATP11C mutations are associated with blood disorders and cancer [1, 4, 7].
How is phosphatidylcholine flippase activity measured?
It can be measured using fluorescent lipid flipping assays, cryo-EM, and cell-based scrambling assays [3, 5, 8].
What is the difference between a flippase and a scramblase?
Flippases use ATP to move specific lipids from the outer to the inner leaflet, while scramblases facilitate bidirectional movement of lipids down their concentration gradient.
Can CRISPR be used to study phosphatidylcholine flippase activity?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are powerful tools to dissect flippase function [1, 6].
What is the role of ATP8B2 in the nervous system?
ATP8B2 is a phosphatidylcholine flippase, and de novo missense variants that impair its activity are associated with neurological disorders.
How does ATP10A contribute to plasma membrane dynamics?
ATP10A translocates phosphatidylcholine and regulates plasma membrane dynamics, influencing endocytosis and exocytosis.
What structural insights exist for phosphatidylcholine flippases?
Cryo-EM structures have revealed conformational changes during the transport cycle, and the ATP11C Q79E mutant structure shows altered phospholipid recognition [3, 7].
What are the therapeutic implications of targeting phosphatidylcholine flippases?
Modulating flippase activity could treat liver diseases, neurological disorders, and cancer by restoring membrane lipid asymmetry [4, 7].
Conclusion
Phosphatidylcholine flippase activity (GO:0140345) is a fundamental molecular function that maintains membrane lipid asymmetry and influences diverse cellular processes. The P4-ATPase family enzymes that catalyze this activity are linked to human diseases ranging from cholestasis to neurological disorders and cancer. Advances in structural biology and CRISPR-based models continue to unravel the mechanistic details and physiological roles of these flippases. EDITGENE provides comprehensive CRISPR services to support researchers in exploring phosphatidylcholine flippase biology and developing therapeutic strategies.
References
- 1. Takatsu H et al.. 2024. De Novo Missense Variations of ATP8B2 Impair Its Phosphatidylcholine Flippase Activity.. Mol Cell Biol 44(11):473-488 PMID: 39219493
- 2. Muranaka Y et al.. 2024. Novel phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane.. Biochem J 481(18):1187-1202 PMID: 39258799
- 3. Xu J et al.. 2022. Conformational changes of a phosphatidylcholine flippase in lipid membranes.. Cell Rep 38(11):110518 PMID: 35294892
- 4. Linton KJ. 2015. Lipid flopping in the liver.. Biochem Soc Trans 43(5):1003-10 PMID: 26517915
- 5. Suzuki H et al.. 1997. The phospholipid flippase activity of gastric vesicles.. J Biol Chem 272(16):10429-34 PMID: 9099684
- 6. Naito T et al.. 2015. Phospholipid Flippase ATP10A Translocates Phosphatidylcholine and Is Involved in Plasma Membrane Dynamics.. J Biol Chem 290(24):15004-17 PMID: 25947375
- 7. Qian Y et al.. 2026. Cryo-EM structure of the ATP11C Q79E mutant reveals the structural basis for altered Phospholipid recognition.. J Biol Chem 302(1):110935 PMID: 41237907
- 8. Teo CF et al.. 2025. A cell-based scrambling assay reveals the phospholipid headgroup preference of TMEM16F on the plasma membrane.. Proc Natl Acad Sci U S A 122(44):e2516822122 PMID: 41166415
